These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22438115)

  • 1. Complete disappearance of uptake of FDG in the multifocal liver hemangioendothelioma after radioembolization therapy using yttrium-90 microspheres.
    Karaman B; Battal B; Alagoz E; Akgun V; Ince S; Ustunsoz B
    Ann Nucl Med; 2012 Jun; 26(5):440-3. PubMed ID: 22438115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective intra-arterial Y-90 microsphere therapy in hemangioendothelioma.
    Laçın S; Küçük O; Oz I; Bılgıç S
    Turk J Gastroenterol; 2011 Feb; 22(1):89-92. PubMed ID: 21480119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres.
    Flamen P; Vanderlinden B; Delatte P; Ghanem G; Ameye L; Van Den Eynde M; Hendlisz A
    Phys Med Biol; 2008 Nov; 53(22):6591-603. PubMed ID: 18978442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of post-Yttrium 90 radioembolization therapy 18F-fluorodeoxyglucose positron emission tomography in patients with liver tumors.
    Obrzut S; McCammack K; Badran KW; Balistreri A; Ou E; Nguyen BJ; Hoh CK; Rose SC
    Clin Imaging; 2017; 42():43-49. PubMed ID: 27875761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embolization of hepatic arterial branches to simplify hepatic blood flow before yttrium 90 radioembolization: a useful technique in the presence of challenging anatomy.
    Karunanithy N; Gordon F; Hodolic M; Al-Nahhas A; Wasan HS; Habib N; Tait NP
    Cardiovasc Intervent Radiol; 2011 Apr; 34(2):287-94. PubMed ID: 20700593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of metastatic load to liver after intraarterial hepatic yttrium-90 radioembolization as evaluated by [18F]fluorodeoxyglucose positron emission tomographic imaging.
    Wong CY; Qing F; Savin M; Campbell J; Gates VL; Sherpa KM; Lewandowski RJ; Nagle C; Salem R
    J Vasc Interv Radiol; 2005 Aug; 16(8):1101-6. PubMed ID: 16105922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordant F-18 FDG PET and Y-90 Bremsstrahlung scans depict selective delivery of Y-90-microspheres to liver tumors: confirmation with histopathology.
    Tehranipour N; AL-Nahhas A; Canelo R; Stamp G; Woo K; Tait P; Gishen P
    Clin Nucl Med; 2007 May; 32(5):371-4. PubMed ID: 17452865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of yttrium-90 microsphere radioembolization of hepatocellular carcinoma as downstaging and bridge before liver transplantation: a case report.
    Khalaf H; Alsuhaibani H; Al-Sugair A; Al-Mana H; Al-Mutawa A; Al-Kadhi Y; Al-Sebayel M
    Transplant Proc; 2010 Apr; 42(3):994-8. PubMed ID: 20430224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.
    Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS
    J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, Efficacy, and Prognostic Factors After Radioembolization of Hepatic Metastases from Breast Cancer: A Large Single-Center Experience in 81 Patients.
    Fendler WP; Lechner H; Todica A; Paprottka KJ; Paprottka PM; Jakobs TF; Michl M; Bartenstein P; Lehner S; Haug AR
    J Nucl Med; 2016 Apr; 57(4):517-23. PubMed ID: 26742710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of intratumoral 99mTc-macroaggregated albumin uptake in patients with colorectal liver metastases scheduled for radioembolization with 90Y-microspheres.
    Ulrich G; Dudeck O; Furth C; Ruf J; Grosser OS; Adolf D; Stiebler M; Ricke J; Amthauer H
    J Nucl Med; 2013 Apr; 54(4):516-22. PubMed ID: 23447653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioembolization with (90)Y resin microspheres for intrahepatic cholangiocellular carcinoma: prognostic factors.
    Soydal C; Kucuk ON; Bilgic S; Ibis E
    Ann Nucl Med; 2016 Jan; 30(1):29-34. PubMed ID: 26370716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer.
    Haug AR; Tiega Donfack BP; Trumm C; Zech CJ; Michl M; Laubender RP; Uebleis C; Bartenstein P; Heinemann V; Hacker M
    J Nucl Med; 2012 Mar; 53(3):371-7. PubMed ID: 22331219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG-PET-CT and whole-body MRI for triage in patients planned for radioembolisation therapy.
    Schmidt GP; Paprottka P; Jakobs TF; Hoffmann RT; Baur-Melnyk A; Haug A; Notohamiprodjo M; Baur-Melnyk A; Nikolaou K; Reiser MF; Rist C
    Eur J Radiol; 2012 Mar; 81(3):e269-76. PubMed ID: 21398060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and Metabolic Imaging of Hepatic Neuroendocrine Tumors Following Radioembolization with 90Y-microspheres.
    Filippi L; Cianni R; Schillaci O; Bagni O
    Curr Med Imaging; 2020; 16(5):545-552. PubMed ID: 32484088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioembolization with 90Y resin microspheres for HCC patients with extensive tumor thrombosis into the extrahepatic vessels.
    Ahmadzadehfar H; Pieper CC; Ezziddin S; Biersack HJ; Meyer C
    Clin Nucl Med; 2014 Mar; 39(3):305-7. PubMed ID: 24458185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioembolization for the treatment of unresectable liver cancer: initial experience at a single center.
    Peynircioğlu B; Cil B; Bozkurt F; Aydemir E; Uğur O; Balkanci F
    Diagn Interv Radiol; 2010 Mar; 16(1):70-8. PubMed ID: 20180183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorbed dose to lesion and clinical outcome after liver radioembolization with 90Y microspheres: a case report of PET-based dosimetry.
    D'Arienzo M; Filippi L; Chiaramida P; Chiacchiararelli L; Cianni R; Salvatori R; Scopinaro F; Bagni O
    Ann Nucl Med; 2013 Aug; 27(7):676-80. PubMed ID: 23605058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arterial radioembolization of malignant liver tumors by yttrium-90 microspheres].
    Tarazov PG
    Vopr Onkol; 2013; 59(4):428-34. PubMed ID: 24032215
    [No Abstract]   [Full Text] [Related]  

  • 20. Colorectal liver metastasis after 90Y radioembolization therapy: pilot study of change in MDCT attenuation as a surrogate marker for future FDG PET response.
    Tochetto SM; Töre HG; Chalian H; Yaghmai V
    AJR Am J Roentgenol; 2012 May; 198(5):1093-9. PubMed ID: 22528898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.